CClinicalTrials.gg
CompletedNCT03817294Updated Sep 9, 2020

Personalised Exercise Training in COPD

An interventional study of Comparison of exercise training modalities in COPD, sponsored by Loughborough University. Completed at 1 site in United Kingdom. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2020-09-09.

Sponsored by Loughborough University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

Exercise training as part of Pulmonary Rehabilitation (PR) has been shown conclusively to improve breathlessness,quality of life and exercise capacity for people with COPD. However generally PR is delivered in a 'one size fits all' approach without considering different aspects of an individual's disease. It is hypothesised that a more personalised approach to PR may yield even better results. However to design a personalised programme of PR we need a better understanding of how different people with COPD respond to different possible exercise training modalities. This study will therefore comprehensively characterise a group of patients and then ask them to complete 3 weeks of exercise training in one of four modalities; conventional cycling, eccentric cycling, one-legged cycling and resistance training. The aim is not to prove which type of training is more effective but to develop an idea of which groups of patients would benefit from which type of training.

Baseline measures would be designed to fully understand how an individual responds to exercise and would therefore be comprised of a variety of endurance tests, strength tests, questionnaires, and measurements of lung capacity and body composition. This is to give as much information as possible to identify different responses to exercise.

Read the detailed description

Chronic obstructive pulmonary disease (COPD) is a highly prevalent condition affecting an estimated 1.2 million people in the UK and is the second most common lung disease after asthma. COPD not only affect the lungs, but is a systemic disease with muscle dysfunction being a significant feature. Exercise, as part of a programme of pulmonary rehabilitation (PR), has been shown to improve exercise capacity and quality of life of patients with COPD. However, despite the effectiveness of PR at a population level, there remains room for improvement. The individual treatment response is heterogeneous with some patients failing to achieve clinically significant improvements, whilst others struggle to adhere to the exercise component or drop out altogether. Currently, whilst exercise intensities (the "dose") are individualised during PR, the character and content of PR is generally provided in a "one size fits all" manner. There is therefore scope to modify the content of PR to meet individual needs and underlying physiology thereby enhancing adherence and benefits.

Precision medicine, tailoring therapy to specific "treatable traits" of an individual's condition, holds the potential to maximise treatment effect whilst minimising adverse effects. The investigators propose the same principles of precision medicine can be used to improve the delivery of PR by identifying an individual's exercise response at enrolment to PR and using this information to personalise exercise training. There are a growing number of diverse, novel training modalities that have been shown to be feasible and potentially efficacious in COPD, offering opportunities for delivering a personalised training programme. A key step in the development of this personalised/precision approach in exercise medicine is the understanding and measurement of the individual exercise pathophysiology that predicts preferential benefits to a particular exercise training modality. However, the relationship between baseline exercise pathophysiology (and indeed other disease and demographic variables) and such a response is currently unknown.

Eccentric exercise, contraction of a muscle as it lengthens, and one-legged cycling are two options for diversifying PR. For a given muscle workload, eccentric exercise results in lower energy demand and oxygen consumption and therefore puts less strain on the cardiopulmonary system. Consequently, this type of exercise may be ideally suited for patients with lung disease, particularly for those who stop exercise due to ventilatory limitations. It may be more tolerable for patients as it causes less breathlessness, whilst allowing greater muscle specific work. Eccentric cycling involves use of a bike with an attached motor which drives the pedals in reverse. The subject must resist the rotation of the pedals to maintain a constant pedal speed, thereby performing eccentric work with their legs. Using eccentric exercise as a training modality had historically been avoided due to the fear of causing muscle damage. High intensity eccentric resistance exercise leads to delayed onset muscle soreness (DOMS) and has been used for many years as a model of inducing muscle damage. However over the last 30 years there have been an increasing number of studies showing comprehensively that if load is gradually increased, muscle damage and soreness is minimal and acceptable. In patient populations, because loads achieved are particularly low, the occurrence of significant muscle damage is even more infrequent and previous work, has demonstrated that eccentric cycling is well tolerated in patients with COPD.

Whole body exercise, such as walking or cycling, requires recruitment of a large muscle mass generating a high oxygen demand. However, there is a disparity between whole body maximal oxygen uptake and muscle maximum aerobic capacity, even in a healthy population, and consequently significant variation in the muscle training stimuli achieved. This is emphasised in patients with COPD with a ventilatory limit to exercise. By exercising a smaller muscle mass, this ventilatory limitation can be bypassed and the individual muscle can be worked at significantly higher intensity. One method to reduce the exercising muscle mass is one-legged cycling. Two randomised controlled trials have demonstrated a greater improvement in V̇O2peak following one-legged cycling compared with two legged cycling in patients with COPD. One-legged cycling has been demonstrated to be a feasible addition to a PR programme and well received by patients and physiotherapists.

This study aims to determine how disease, demographic and exercise physiological variables recorded at baseline relate to subsequent perception and progression of novel training modalities compared to conventional training. The investigators will perform a comprehensive assessment of physiological response to exercise at baseline in terms of exercise capacity, exercise limitation, muscle volume and strength, physical activity, frailty and muscle composition. Participants will then be randomly allocated to one of 4 training modalities; eccentric cycling, one-legged cycling, concentric (traditional 2-legged cycling), or lower limb resistance training.

This is a pilot/feasibility study with the broad aim of identifying potential subphenotypes of patients with COPD that might respond preferentially to particular modalities of training. This knowledge is crucial to the development of definitive clinical trials of such exercise medicine interventions that could be delivered in routine clinical practice. The specific aims are:

  1. To characterise in detail the underlying pulmonary and systemic pathophysiological characteristics of patients with COPD who are disabled by exercise limitation.
  2. To measure progression of training loads during each training intervention relative to baseline values.
  3. To determine how baseline characteristics and pathophysiology relate to training progression and exercise experience.
02

Conditions studied

  • COPD
03

In context

Lead sponsor

Loughborough University is the lead sponsor of 71 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male or Female, aged 40 years or above
  • Diagnosis of COPD
  • FEV1/FVC \<0.7 and FEV1 \< 80% predicted
  • Medical Research Council (MRC) dyspnoea scale ≥3
  • Participant is willing and able to give informed consent for participation in the study.
  • Stable dose of current regular medication for at least 4 weeks prior to study entry.
  • Participant has clinically acceptable ECG at enrolment.
  • Able (in the Investigators opinion) and willing to comply with all study requirements.
  • English speaking

Exclusion criteria

Exclusion Criteria:

  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
  • Any major or uncontrolled comorbidity that would impair the participant's ability to exercise or would mean exercise was unsafe.
  • Participants who have participated in another research study involving an investigational product in the past 12 weeks
  • Participation in pulmonary rehabilitation in the preceding 6 months
  • Participation in another research study involving exercise training in the preceding 6 months
  • Acute exacerbation in the preceding 4 weeks (would become eligible 4 weeks following recovery)
  • Scheduled elective surgery or other procedures requiring general anaesthesia during the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Active comparator
    Eccentric cycling

    Other: Comparison of exercise training modalities

  • Active comparator
    Concentric cycling

    Other: Comparison of exercise training modalities

  • Active comparator
    Single leg cycling

    Other: Comparison of exercise training modalities

  • Active comparator
    Lower limb resistance training

    Other: Comparison of exercise training modalities

Interventions

  • OtherComparison of exercise training modalities

    As above

06

What researchers measure

Primary outcomes

  1. Training Progression (Total work during training relative to baseline)

    (Total load during training in kJ or kg depending on exercise modality)/(load performed at baseline). This will therefore be presented as a standardised proportion (%) with no unit of measurement. Load refers to the total force production during exercise. For 2 leg and 1 leg concentric cycling and eccentric cycling this refers power output of the ergometer - total energy produced. For resistance exercise this refers to total weight lifted during training (in kg), i.e. weight lifted multiplied by number of repetitions.

    Time frame: 3 weeks

  2. Training adherence

    (percentage of training sessions attended)

    Time frame: 3 weeks

  3. Subjective exercise experience scale during each exercise modality

    Validated 12 point questionnaire with each question scoring from 1 (not at all) to 7(very much so). 3 domains - fatigue (high score=high fatigue), positive well-being (high score=high positive well being) and psychological distress (high score=high distress). Each domain represents 4 questions and the score for each domain (from 4-28) will be presented. Completed during all 4 exercise modalities (eccentric cycling, resistance training, single leg cycling and concentric cycling) for each participant

    Time frame: Week 2

Secondary outcomes

  1. Experience of different exercise modalities - Qualitative questionnaire

    Structured questionnaire tailored to this study requiring short answers. Exploring preference and experience of each training modality. Note: This is not a scale questionnaire, but a short answer questionnaire with results presented as 'themes'

    Time frame: 3 weeks

  2. Exercise capacity - peak V̇O2 during a maximal incremental 2 leg cycle test

    ml.min-1

    Time frame: Baseline

  3. Exercise capacity - peak V̇O2 during a maximal incremental 1 leg cycle test

    ml.min-1

    Time frame: Baseline

  4. Inspiratory capacity during maximal 2 leg cycling

    change from baseline (ml)

    Time frame: Baseline

  5. Functional capacity - constant work rate cycling test

    Performed at 75% of maximum achieved power during two legged maximal incremental cycle test. Participants will be asked to cycle at a constant power output until volitional exhaustion. Outcome will be time (mins)

    Time frame: Baseline

  6. Functional capacity - measured by Timed up-and-go test

    Time (secs) taken to get up from a chair, walk 3m, return to the chair and sit down.

    Time frame: Baseline

  7. Muscle strength - maximal concentric quadriceps strength

    Isokinetic knee flexion/extension using dynamometry. Peak torque (Nm) and angle of peak torque recorded

    Time frame: Baseline

  8. Muscle strength - maximal eccentric quadriceps strength

    Isokinetic knee flexion/extension using dynamometry. Peak torque (Nm) and angle of peak torque recorded

    Time frame: Baseline

  9. Muscle strength - 10 rep max Leg extension

    Maximum load that participants can lift with two legs for 10 repetitions (kg)

    Time frame: Baseline

  10. Health related quality of life - St George's respiratory questionnaire

    50 item questionnaire to measure health status (quality of life) in patients with diseases of airways obstruction. Scores are calculated for three domains: Symptoms, Activity and Impacts (Psycho-social) as well as a total score (from 0-100). The minimum change score of 4 units is established as clinically relevant.

    Time frame: Baseline

  11. Frailty - Groningen Frailty Index

    total score out of 15. A score of 4 of more indicates moderate to severe frailty

    Time frame: Baseline

  12. Balance - Activities specific balance scale (ABC scale)

    16 item score (each point answered from 0-10 with 0 representing no confidence and 100 representing complete confidence with performing specified activity without loosing balance). Total score given as an average of all questions (presented as a percentage from 0-100%). Lower scores represent worse balance

    Time frame: Baseline

  13. Physical activity - 7-day activity monitor

    Percentage of time in light and moderate-to-vigorous physical activity

    Time frame: Baseline

  14. Muscle architectural measures seen on muscle biopsy

    Fibre type composition - percentage of type 1 and type 2 muscle fibres

    Time frame: Baseline

  15. Muscle architectural measures seen on muscle biopsy

    Fibre size - mean fibre cross sectional area (micrometer2)

    Time frame: Baseline

  16. Capillary density on muscle biopsy

    Number of capillaries per mm2

    Time frame: Baseline

  17. Body composition - bioelectrical impedance

    fat free mass index (kg/m2)

    Time frame: Baseline

  18. Breathlessness during exercise - Multidimensional dyspnoea profile

    Validated questionnaire exploring multiple aspects of dyspnoea. Recorded at baseline and during each of 4 exercise modalities (eccentric cycling, concentric cycling, single leg cycling and lower limb resistance training). Pooled results of each question will be presented. This is not a traditional 'scale' with a 'total score' but produces a multidimensional picture of breathlessness and has been well described in breathlessness research. It is being used as a way to categorise breathlessness response or phenotype.

    Time frame: Baseline

07

Study locations

1 site
  • Loughborough University
    Loughborough, LE11 3TU, United Kingdom
08

References and documents

Publications

  • Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, Gosker HR, Gosselink R, Hayot M, Hussain SN, Janssens W, Polkey MI, Roca J, Saey D, Schols AM, Spruit MA, Steiner M, Taivassalo T, Troosters T, Vogiatzis I, Wagner PD; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62. doi: 10.1164/rccm.201402-0373ST. PubMed 24787074 ↗
  • Troosters T, Gosselink R, Decramer M. Exercise training in COPD: how to distinguish responders from nonresponders. J Cardiopulm Rehabil. 2001 Jan-Feb;21(1):10-7. doi: 10.1097/00008483-200101000-00004. PubMed 11271652 ↗
  • Camillo CA, Osadnik CR, van Remoortel H, Burtin C, Janssens W, Troosters T. Effect of "add-on" interventions on exercise training in individuals with COPD: a systematic review. ERJ Open Res. 2016 Mar 29;2(1):00078-2015. doi: 10.1183/23120541.00078-2015. eCollection 2016 Jan. PubMed 27730178 ↗
  • Rocha Vieira DS, Baril J, Richard R, Perrault H, Bourbeau J, Taivassalo T. Eccentric cycle exercise in severe COPD: feasibility of application. COPD. 2011 Aug;8(4):270-4. doi: 10.3109/15412555.2011.579926. Epub 2011 Jul 5. PubMed 21728805 ↗
  • Bjorgen S, Helgerud J, Husby V, Steinshamn S, Richadson RR, Hoff J. Aerobic high intensity one-legged interval cycling improves peak oxygen uptake in chronic obstructive pulmonary disease patients; no additional effect from hyperoxia. Int J Sports Med. 2009 Dec;30(12):872-8. doi: 10.1055/s-0029-1238292. PubMed 19821224 ↗
  • Evans RA, Dolmage TE, Mangovski-Alzamora S, Romano J, O'Brien L, Brooks D, Goldstein RS. One-Legged Cycle Training for Chronic Obstructive Pulmonary Disease. A Pragmatic Study of Implementation to Pulmonary Rehabilitation. Ann Am Thorac Soc. 2015 Oct;12(10):1490-7. doi: 10.1513/AnnalsATS.201504-231OC. PubMed 26291542 ↗

Study documents

  • Informed consent form · Jul 13, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03817294
Lead sponsor
Loughborough University
Responsible party
Dr Tom Ward (Clinical PhD student, Loughborough University) — Principal investigator
First posted
Jan 25, 2019
Start date
Oct 3, 2018
Primary completion
Aug 2, 2019
Completion
Aug 2, 2019
Last update
Sep 9, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion